These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Keeping apples and oranges separate: reassessing clinical trials that use composite end points as their primary outcome. Chan PS; Nallamothu BK; Hayward RA J Am Coll Cardiol; 2006 Aug; 48(4):850; author reply 851-2. PubMed ID: 16904570 [No Abstract] [Full Text] [Related]
3. Assessment of analysis by gender in the Cochrane reviews as related to treatment of cardiovascular disease. Johnson SM; Karvonen CA; Phelps CL; Nader S; Sanborn BM J Womens Health (Larchmt); 2003 Jun; 12(5):449-57. PubMed ID: 12869292 [TBL] [Abstract][Full Text] [Related]
8. Implications of stroke prevention trials: treatment of global risk. Elkind MS Neurology; 2005 Jul; 65(1):17-21. PubMed ID: 16009880 [TBL] [Abstract][Full Text] [Related]
9. Clinical trials in cardiovascular medicine in an era of marginal benefit, bias, and hyperbole. Loscalzo J Circulation; 2005 Nov; 112(20):3026-9. PubMed ID: 16286598 [No Abstract] [Full Text] [Related]
11. Pilot trials in clinical research: of what value are they? Loscalzo J Circulation; 2009 Apr; 119(13):1694-6. PubMed ID: 19349331 [No Abstract] [Full Text] [Related]
12. Bibliography. Current world literature. Therapy and clinical trials. Curr Opin Lipidol; 2002 Dec; 13(6):671-2. PubMed ID: 12523337 [No Abstract] [Full Text] [Related]
13. Bibliography. Current world literature. Therapy and clinical trials. Curr Opin Lipidol; 2004 Dec; 15(6):681-92. PubMed ID: 15529028 [No Abstract] [Full Text] [Related]
15. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Thompson PD; Buchner D; Pina IL; Balady GJ; Williams MA; Marcus BH; Berra K; Blair SN; Costa F; Franklin B; Fletcher GF; Gordon NF; Pate RR; Rodriguez BL; Yancey AK; Wenger NK; ; Circulation; 2003 Jun; 107(24):3109-16. PubMed ID: 12821592 [No Abstract] [Full Text] [Related]
16. Bibliography. Current world literature. Therapy and clinical trials. Curr Opin Lipidol; 2007 Dec; 18(6):656-82. PubMed ID: 17993812 [No Abstract] [Full Text] [Related]
17. Status of women in cardiovascular clinical trials. Kim ES; Menon V Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):279-83. PubMed ID: 19221204 [No Abstract] [Full Text] [Related]
18. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Dzau VJ; Antman EM; Black HR; Hayes DL; Manson JE; Plutzky J; Popma JJ; Stevenson W Circulation; 2006 Dec; 114(25):2850-70. PubMed ID: 17179034 [No Abstract] [Full Text] [Related]
19. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292 [TBL] [Abstract][Full Text] [Related]
20. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]